| 2024-11-22 |
[Comment] Prostate radiotherapy in the era of intensified systemic treatment of metastatic prostate cancer |
Cristian Udovicich, Andrew Loblaw |
|
| 2024-11-22 |
[Correspondence] North Abyei: the humanitarian and health crisis in Sudan |
Yousif Ali, Emmanuel Edwar Siddig, Ayman Ahmed |
|
| 2024-11-22 |
[Editorial] The next 1000 days: the forgotten ages of child health |
The Lancet |
|
| 2024-11-22 |
[Correspondence] Pembrolizumab for locally advanced cervical cancer – Authors' reply |
Domenica Lorusso, Karin Yamada, Kan Li, Annamaria Cerrotta, Gabriella Macchia |
|
| 2024-11-22 |
[Correspondence] Pembrolizumab for locally advanced cervical cancer |
Maximilian P Schmid, Primoz Petric, Umesh Mahantshetty, Christian Kirisits, Kari Tanderup, Ina Jürgenliemk-Schulz, Jacob Lindegaard, Richard Pötter |
|
| 2024-11-22 |
[Correspondence] The UN World Conjoined Twins Day—a call to global action |
Abdullah A Al Rabeeah, Ziad A Memish |
|
| 2024-11-22 |
[Perspectives] Instrument of empires |
Mandip Aujla |
|
| 2024-11-22 |
[Perspectives] Making the invisible visible: using art to explore the facade of objectivity in medicine |
Kerri Davidson, Robert Rock, Cyra Levenson, Anna Reisman |
|
| 2024-11-22 |
[World Report] The changing story of access to medicines |
Udani Samarasekera |
|
| 2024-11-22 |
[Perspectives] Meditations on law, race, ownership, and bodies |
Harriet A Washington |
|
| 2024-11-22 |
[Articles] Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design |
Alberto Bossi, Stéphanie Foulon, Xavier Maldonado, Paul Sargos, Ray MacDermott, Paul Kelly, Aude Fléchon, Bertrand Tombal, Stephane Supiot, Dominik Berthold, Philippe Ronchin, Gabriel Kacso, Naji Salem, Fabio Calabro, Jean-François Berdah, Ali Hasbini, Ma |
|
| 2024-11-22 |
[Comment] Offline: Can public health overcome its colonial history? |
Richard Horton |
|
| 2024-11-22 |
[Clinical Picture] Skin biopsy findings of dyskeratotic keratinocytes and vacuolar interface change in a patient with Still's disease |
Derrick H Y Chong, Sylvia Pasternak, Trudy Taylor, Sam Armstrong, Kerri Purdy, Luke Y C Chen |
|
| 2024-11-22 |
[Correspondence] Should WHO partner with TikTok to combat misinformation? |
Marco Zenone, Nora Kenworthy |
|
| 2024-11-22 |
[Obituary] George Berci |
Geoff Watts |
|
| 2024-11-22 |
[Correspondence] Pembrolizumab for locally advanced cervical cancer |
Binhua Dong, Yong Lu, Yue Wang, Pengming Sun, Huachun Zou |
|
| 2024-11-22 |
[Correspondence] Declaration of Helsinki's missed opportunity for healthy volunteer trials |
François Bompart, Jill A Fisher, Sucheta Banerjee Kurundkar, François Hirsch, Shadreck Mwale |
|
| 2024-11-22 |
[Correspondence] Pembrolizumab for locally advanced cervical cancer |
Naoya Murakami, Noriyuki Okonogi, Yasuhisa Terao, Naoto Shikama |
|
| 2024-11-22 |
[Correspondence] AI ethics in medical research: the 2024 Declaration of Helsinki |
Howard Lopes Ribeiro Junior |
|
| 2024-11-22 |
[Correspondence] Pembrolizumab for locally advanced cervical cancer |
Mitchell Kamrava, Sushil Beriwal |
|
| 2024-11-22 |
[Series] The next 1000 days: building on early investments for the health and development of young children |
Catherine E Draper, Aisha K Yousafzai, Dana C McCoy, Jorge Cuartas, Jelena Obradović, Sunil Bhopal, Jane Fisher, Joshua Jeong, Sonja Klingberg, Kate Milner, Lauren Pisani, Aditi Roy, Jonathan Seiden, Christopher R Sudfeld, Stephanie V Wrottesley, Günther |
|
| 2024-11-22 |
[Series] The cost of not investing in the next 1000 days: implications for policy and practice |
Milagros Nores, Claudia Vazquez, Emily Gustafsson-Wright, Sarah Osborne, Jorge Cuartas, Mark J Lambiris, Dana C McCoy, Florencia Lopez-Boo, Jere Behrman, Raquel Bernal, Catherine E Draper, Anthony D Okely, Mark S Tremblay, Aisha K Yousafzai, Joan Lombardi |
|
| 2024-11-22 |
[Comment] The first and next 1000 days: a continuum for child development in early life |
Victor M Aguayo, Pia R Britto |
|
| 2024-11-22 |
[Articles] Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants |
NCD Risk Factor Collaboration (NCD-RisC) |
|
| 2024-11-22 |
[Comment] Rising diabetes, lagging treatment, and the need for better systems |
Leonor Guariguata, Natasha Sobers |
|
| 2024-11-22 |
[Comment] Perioperative immunotherapy in soft tissue sarcomas |
Antoine Italiano |
|
| 2024-11-22 |
[Articles] Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial |
Yvonne M Mowery, Karla V Ballman, Angela M Hong, Scott M Schuetze, Andrew J Wagner, Varun Monga, Rachel S Heise, Steven Attia, Edwin Choy, Melissa A Burgess, Susie Bae, David I Pryor, Brian A Van Tine, Gabriel Tinoco, Bartosz Chmielowski, Carolyn Freeman, |
|
| 2024-11-22 |
[World Report] Japan's lonely deaths: a social epidemic |
Megan Tatum |
|
| 2024-11-22 |
[Comment] Equitable access to pandemic products demands stronger public governance |
Adam Strobeyko, Caesar A Atuire, Ruth Faden, Calvin W L Ho, Vitor Ido, Mohga Kamal-Yanni, Matthew Kavanagh, Katherine Littler, Lauren Paremoer, Alexandra L Phelan, Katerini T Storeng, Ross Upshur, Suerie Moon |
|
| 2024-11-15 |
[Comment] Glofit-GemOx: a new treatment paradigm in relapsed or refractory diffuse large B-cell lymphoma? |
Anna Sureda, Astrid Pavlosky |
|
| 2024-11-15 |
[Review] Cardiogenic shock |
Enzo Lüsebrink, Leonhard Binzenhöfer, Marianna Adamo, Roberto Lorusso, Alexandre Mebazaa, David A Morrow, Susanna Price, Jacob C Jentzer, Daniel Brodie, Alain Combes, Holger Thiele |
|
| 2024-11-15 |
[Editorial] Trump, health, science, and the next 4 years |
The Lancet |
|
| 2024-11-15 |
[Perspectives] Rewriting the female body |
Gabriel Weston |
|
| 2024-11-15 |
[Perspectives] James Baldwin: ignorance, power, justice |
Seye Abimbola |
|
| 2024-11-15 |
[Clinical Picture] Central conducting lymphatic anomaly with pulmonary lymphatic dysplasia causes restrictive lung disease and chronic pleural effusion |
Mudit Gupta, Ganesh Krishnamurthy, Christopher L Smith |
|
| 2024-11-15 |
[Perspectives] Elizabeth Kimani-Murage: exploring climate change and nutrition |
Udani Samarasekera |
|
| 2024-11-15 |
[World Report] Brazil considers obesity discrimination law |
Tony Kirby |
|
| 2024-11-15 |
[World Report] Brazil-led G20 to target hunger, poverty, and inequities |
John Zarocostas |
|
| 2024-11-15 |
[Comment] Offline: Rediscovering a progressive America |
Richard Horton |
|
| 2024-11-15 |
[Seminar] Oesophageal cancer |
Hong Yang, Feng Wang, Christopher L Hallemeier, Toni Lerut, Jianhua Fu |
|
| 2024-11-15 |
[Comment] Health taxes: missed opportunities for health and health-care financing |
Helen Clark, Cathrine Lofthus, Robert Marten, Kumanan Rasanathan |
|
| 2024-11-15 |
[Obituary] Thomas Killip III |
Geoff Watts |
|
| 2024-11-15 |
[Articles] Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial |
Jeremy S Abramson, Matthew Ku, Mark Hertzberg, Hui-Qiang Huang, Christopher P Fox, Huilai Zhang, Dok Hyun Yoon, Won-Seog Kim, Haifaa Abdulhaq, William Townsend, Charles Herbaux, Jan M Zaucha, Qing-Yuan Zhang, Hung Chang, Yanyan Liu, Chan Yoon Cheah, Herve |
|
| 2024-11-15 |
[Correspondence] Refugees and asylees with disabilities: a call for economic integration |
Mustafa Rfat, Josephine Nabayinda, Samuel Kizito, Mansha Mirza |
|
| 2024-11-15 |
[Department of Error] Department of Error |
|
|
| 2024-11-15 |
[Correspondence] Nakalanga syndrome and hypopituitarism |
Benjamin De Wilde, Robert Colebunders |
|
| 2024-11-15 |
[Correspondence] Problems in defining medicalised FGM and proposed solutions |
Arianne Shahvisi, Jasmine Abdulcadir, Mireia Garcés de Marcilla, Tammary Chepkoech Rotich, Brian D Earp |
|
| 2024-11-15 |
[Correspondence] Misinformation targeting replicon vaccine recipients: an urgent public health ethical issue |
Hiroyasu Ino, Yoshiyuki Takimoto, Eisuke Nakazawa |
|
| 2024-11-15 |
[Comment] Mexico Summit 20 years on—gains and challenges |
Tikki Pang, Ulysses Panisset, Francisco Becerra-Posada, Julio Frenk |
|
| 2024-11-15 |
[Articles] Induced pluripotent stem-cell-derived corneal epithelium for transplant surgery: a single-arm, open-label, first-in-human interventional study in Japan |
Takeshi Soma, Yoshinori Oie, Hiroshi Takayanagi, Shoko Matsubara, Tomomi Yamada, Masaki Nomura, Yu Yoshinaga, Kazuichi Maruyama, Atsushi Watanabe, Kayo Takashima, Zaixing Mao, Andrew J Quantock, Ryuhei Hayashi, Kohji Nishida |
|
| 2024-11-15 |
[Comment] Opening the door to widespread iPSC-derived regenerative therapy for corneal epithelial opacity |
Yasuhiko Hirami, Michiko Mandai |
|
| 2024-11-15 |
[Correspondence] Concerns regarding Gaza mortality estimates |
Andrew Gilbert |
|
| 2024-11-15 |
[Correspondence] Concerns regarding Gaza mortality estimates |
Rafael Beyar, Karl Skorecki |
|
| 2024-11-15 |
[Correspondence] Concerns regarding Gaza mortality estimates |
Ruth Oratz, Steven Roth, Joel Zivot, Yael Halaas |
|
| 2024-11-15 |
[Correspondence] Concerns regarding Gaza mortality estimates – Authors' reply |
Rasha Khatib, Martin McKee, Salim Yusuf |
|
| 2024-11-15 |
[Articles] Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021 |
GBD 2021 Global Stillbirths Collaborators |
|
| 2024-11-15 |
[Comment] Counting every newborn: liveborn or stillborn |
Hannah Blencowe, Lucia Hug |
|
| 2024-11-15 |
[Correspondence] Pernkopf was not alone: the Nazi origins of the Spalteholz–Spanner atlas |
Claudia Krebs, Katerina Schwab, Manjot Kahlon, Ivica Bratanovic, Aleteia Greenwood, Shelly Rosenblum, Sabine Hildebrandt |
|
| 2024-11-15 |
[World Report] Research focus: the Genes & Health Study |
Talha Burki |
|
| 2024-11-15 |
[Comment] Non-communicable diseases: can implementation research change the game for policy and practice? |
Kumanan Rasanathan, Phyllis Dako-Gyeke, Wanrudee Isaranuwatchai, Yodi Mahendradhata, Morven Roberts, Giulia Loffreda, Sarah Rylance, Bente Mikkelsen |
|
| 2024-11-08 |
[Correspondence] Sparsentan and kidney protection: improved medullary oxygenation? |
Dion Groothof, Reinold O B Gans, Stephan J L Bakker |
|
| 2024-11-08 |
[Editorial] Promises and pitfalls: UK health under Labour |
The Lancet |
|
| 2024-11-08 |
[Correspondence] Treatment of vulnerable atherosclerotic plaques: the PREVENT trial |
Chinmay Khandkar, Jordan Fulcher, Sanjay Patel, Anthony Keech |
|
| 2024-11-08 |
[Correspondence] Violence against women and girls in Sudan's conflict zones |
Ibrahim Nagmeldin Hassan |
|
| 2024-11-08 |
[Perspectives] A history of hydrotherapy and mental health |
Matthew Smith |
|
| 2024-11-08 |
[Obituary] Jeffrey Stuart Weber |
Geoff Watts |
|
| 2024-11-08 |
[Correspondence] Treatment of vulnerable atherosclerotic plaques: the PREVENT trial |
Giuseppe Ferrante, Gianluca Mincione, Antonio Colombo |
|
| 2024-11-08 |
[Correspondence] Treatment of vulnerable atherosclerotic plaques: the PREVENT trial |
Shichu Liang, Junyan Zhang, Zhongxiu Chen, Hua Wang, Yong He |
|
| 2024-11-08 |
[World Report] Fears for Georgia's NGOs |
Sharmila Devi |
|
| 2024-11-08 |
[Correspondence] Adjuvant everolimus after renal cell carcinoma nephrectomy |
Yao-Ning Feng, Li Xiao, Guang-Yu Xie |
|
| 2024-11-08 |
[Comment] Offline: Being one of the lucky ones |
Richard Horton |
|
| 2024-11-08 |
[World Report] New HIV drugs: access debates |
Sophie Cousins |
|
| 2024-11-08 |
[Correspondence] Treatment of vulnerable atherosclerotic plaques: the PREVENT trial – Authors' reply |
Seung-Jung Park, Jung-Min Ahn, Do-Yoon Kang, Duk-Woo Park |
|
| 2024-11-08 |
[Department of Error] Department of Error |
|
|
| 2024-11-08 |
[Clinical Picture] Intravascular large B-cell lymphoma presenting with non-occlusive mesenteric ischaemia |
Kimihiko Nakamura, Toru Inoue, Atsushi Takada |
|
| 2024-11-08 |
[Comment] Mpox surveillance: the need for enhanced testing and genomic epidemiology |
Jeremy R Wang |
|
| 2024-11-08 |
[Correspondence] Treatment of vulnerable atherosclerotic plaques: the PREVENT trial |
Ioannis Merinopoulos, Simon C Eccleshall, Vassilios S Vassiliou |
|
| 2024-11-08 |
[Correspondence] Treatment of vulnerable atherosclerotic plaques: the PREVENT trial |
Kyriakos Dimitriadis, Nikolaos Pyrpyris, Konstantinos Tsioufis |
|
| 2024-11-08 |
[Perspectives] Marina Romanello: tracking climate change and health |
Aarathi Prasad |
|
| 2024-11-08 |
[Correspondence] Adjuvant everolimus after renal cell carcinoma nephrectomy – Authors' reply |
Christopher W Ryan, Catherine M Tangen, Primo N Lara |
|
| 2024-11-08 |
[Correspondence] Sparsentan and kidney protection: improved medullary oxygenation? – Authors' reply |
Donald Kohan, Jula Inrig, Brad H Rovin, Radko Komers |
|
| 2024-11-08 |
[Articles] Effectiveness, cost-effectiveness, and positive externalities of integrated chronic care for adults with major depressive disorder in Malawi (IC3D): a stepped-wedge, cluster-randomised, controlled trial |
Ryan K McBain, Owen Mwale, Kondwani Mpinga, Myrrah Kamwiyo, Waste Kayira, Todd Ruderman, Emilia Connolly, Samuel I Watson, Emily B Wroe, Fabien Munyaneza, Luckson Dullie, Giuseppe Raviola, Stephanie L Smith, Kazione Kulisewa, Michael Udedi, Vikram Patel, |
|
| 2024-11-08 |
[Comment] Global mental health and collaborative care |
Michael Berk, Lana J Williams, Dan J Stein |
|
| 2024-11-08 |
[Comment] Present and future of functional measurements in coronary revascularisation |
Leonie M Becker, Martin J Swaans |
|
| 2024-11-08 |
[Articles] Quantitative flow ratio versus fractional flow reserve for coronary revascularisation guidance (FAVOR III Europe): a multicentre, randomised, non-inferiority trial |
Birgitte Krogsgaard Andersen, Martin Sejr-Hansen, Luc Maillard, Gianluca Campo, Truls Råmunddal, Barbara E Stähli, Vincenzo Guiducci, Luigi Di Serafino, Javier Escaned, Ignacio Amat Santos, Ramón López-Palop, Ulf Landmesser, Ruthe Storgaard Dieu, Hernán M |
|
| 2024-11-08 |
[Review] The 2024 report of the Lancet Countdown on health and climate change: facing record-breaking threats from delayed action |
Marina Romanello, Maria Walawender, Shih-Che Hsu, Annalyse Moskeland, Yasna Palmeiro-Silva, Daniel Scamman, Zakari Ali, Nadia Ameli, Denitsa Angelova, Sonja Ayeb-Karlsson, Sara Basart, Jessica Beagley, Paul J Beggs, Luciana Blanco-Villafuerte, Wenjia Cai, |
|
| 2024-11-08 |
[Perspectives] Illustrating the body |
Roger Kneebone |
|
| 2024-11-08 |
[Department of Error] Department of Error |
|
|
| 2024-11-08 |
[Correspondence] Dengue epidemic: Pakistan on alert |
Shiza Aftab, Eesha Yaqoob, Saad Javed |
|
| 2024-11-08 |
[World Report] Research focus: GARDP |
Talha Burki |
|
| 2024-11-08 |
[Articles] Genetic sequencing analysis of monkeypox virus clade I in Republic of the Congo: a cross-sectional, descriptive study |
Claude Kwe Yinda, Félix Koukouikila-Koussounda, Pembe Issamou Mayengue, Reiche Golmard Elenga, Benjamin Greene, Missiani Ochwoto, Ghislain Dzeret Indolo, Yanne Vanessa Thiécesse Mavoungou, Dachel Aymard Eyenet Boussam, Bani Reize Vishnou Ampiri, Chastel C |
|
| 2024-11-08 |
[Comment] To keep health as a unifying force, we must put resources into tackling health misinformation and disinformation |
Jessamy Bagenal, Sian Crucefix, Chloe Wilson, Tim Dehnel, Hugh Thomas, Pierre Nauleau, Claire Lenahan, Ursula Hofer |
|
| 2024-11-08 |
[Comment] Addressing global gun violence: a Lancet Commission on Global Gun Violence and Health |
Adnan A Hyder, Lorena Barberia, Lancet Commission on Global Gun Violence and Health |
|
| 2024-11-08 |
[Comment] Priorities for sickle cell disease global research and implementation |
Ambroise Wonkam, Nchangwi Syntia Munung, Aldiouma Guindo, Obiageli Nnodu |
|
| 2024-11-01 |
[Viewpoint] Striving for balance in decisions on antenatal pharmacotherapy |
Charlotte Koldeweij, Verna AAM Jans, Catriona Waitt, Rick Greupink, Kim LHE Vanden Auweele, Bryony D Franklin, Hubertina CJ Scheepers, Saskia N de Wildt |
|
| 2024-11-01 |
[Editorial] Hope for rare diseases |
The Lancet |
|
| 2024-11-01 |
[Correspondence] Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial – Authors' reply |
Götz Thomalla, Susanne Bonekamp, Jens Fiehler, Martin Bendszus |
|
| 2024-11-01 |
[Perspectives] Grief, hope, and courage |
Gavin Francis |
|
| 2024-11-01 |
[Perspectives] Landscapes of recovery |
Kate Womersley |
|
| 2024-11-01 |
[World Report] Harris or Trump? Health in the US election |
Susan Jaffe |
|
